He is on the Board of Directors at Sucampo Pharmaceuticals, Inc., Edge Therapeutics, Inc., Geron Corp. and Avior Computing Corp. Dr. Spiegel was previously employed as an Independent Director by Weifa ASA, Chief Medical Officer by PTC Therapeutics, Inc., an Independent Director by Talon Therapeutics, Inc., an Independent Director by Capstone Therapeutics Corp., Chief Medical Officer by Schering-Plough Research Institute, and Senior Vice President by Worldwide Clinical Research, Inc. He also served on the board at The Cancer Institute of New Jersey and CancerCare of New Jersey. He received his undergraduate degree from Yale University and a doctorate degree from the University of Pennsylvania.